Showing results (1081-1090 of 1,919) with videos related to
Sort By:
Pageof 192
Current Drug Metabolism|May 16, 2009
Methodological uncertainty in quantitative prediction of human hepatic clearance from in vitro experimental systemsD Hallifax, J B HoustonCurrent Drug Metabolism|August 20, 2009
Calpains as a target for therapy of neurodegenerative diseases: putative role of lithiumAntoni Camins, Natalia Crespo-Biel, Félix Junyent, et al.Current Drug Metabolism|August 20, 2009
Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effectsJörg Thomas Hartmann, Michael Haap, Hans-Georg Kopp, et al.Current Drug Metabolism|August 20, 2009
Transcriptional regulation of cytochrome p450 genes by the nuclear receptor hepatocyte nuclear factor 4-alphaRamiro Jover, Marta Moya, M José Gómez-LechónCurrent Drug Metabolism|April 22, 2010
Pathobiology of chronic inflammatory skin diseases: interplay between keratinocytes and immune cells as a target for anti-inflammatory drugsC Albanesi, S PastoreCurrent Drug Metabolism|April 3, 2010
Comparison of enzyme kinetic parameters obtained in vitro for reactions mediated by human CYP2C enzymes including major CYP2C9 variantsD Rokitta, U FuhrCurrent Drug Metabolism|April 3, 2010
Nanoparticles for tumor targeted therapies and their pharmacokineticsJianqiu Wang, Meihua Sui, Weimin FanCurrent Drug Metabolism|August 26, 2009
Structure, function, regulation and polymorphism of human cytochrome P450 2A6Yuan Ming Di, Vivian Deh-Wei Chow, Li-Ping Yang, et al.Current Drug Metabolism|December 29, 2005
Pharmacokinetics of dihydroergocristine and its major metabolite 8'-hydroxy-dihydroergocristine in human plasmaBeatriz Bicalho, Giovanni C Guzzo, Sergio Lilla, et al.Current Drug Metabolism|December 29, 2005
Improving cancer therapeutics by molecular profilingJavier Corchero, Pedro M Fernández-SalgueroPageof 192